The comments made on Wednesday by the head of the EMA contradict the advice given a day earlier by an expert panel in Germany that prompted the German government to restrict the use of the shot in people under 60
Photo for representational purpose
The European Medicines Agency says there is “no evidence” that would support restricting use of AstraZeneca's coronavirus vaccine in any population despite reports of rare blood clots associated with the shot.
ADVERTISEMENT
The comments made on Wednesday by the head of the EMA contradict the advice given a day earlier by an expert panel in Germany that prompted the German government to restrict the use of the shot in people under 60.
EMA chief Emer Cooke said that “according to the current scientific knowledge, there is no evidence that would support restricting the use of this vaccine in any population.”
Cooke said that the assessment was based on 62 cases of unusual blood clots, including 14 deaths, reported to EMA by March 22.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
